Drotrecogin alfa

Xigris

BrazilCancelledAuthorised 2 Sept 2002

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Xigris (20MG/Vial)Canada · 20 MG / VIAL · Powder For Solution · Eli Lilly Canada INCSame brand
Xigris (5MG/Vial)Canada · 5 MG / VIAL · Powder For Solution · Eli Lilly Canada INCSame brand
XigrisEuropean Union · Eli Lilly Nederland B.V.Same brand
XigrisUnited States · 5MG · Injection · Eli Lilly and CompanySame brand
XigrisUnited States · 20MG · Injection · Eli Lilly and CompanySame brand

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Drotrecogin alfa

Xigris

BrazilCancelledAuthorised 2 Sept 2002

Ask Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Anvisa, Brazil

Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.

Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substance: Drotrecogin alfa
Register: Brazil (Anvisa)
Status: Cancelled
Status in the register: Inativo
Authorised: 2 Sept 2002
Registration: 112600075
Marketing authorisation holder: Eli Lilly do Brasil Ltda
Procedure: Registered